ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,669Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 208

$816K Total Retail Price of All Prescriptions

Rank: 10 out of 208

765 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 765 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

0% of this provider’s 10,367 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
CARVEDILOL 803 696 1 3
ISOSORBIDE MONONITRATE ER 552 509 2 10
AMLODIPINE BESYLATE 545 482 3 5
ATORVASTATIN CALCIUM 486 427 4 11
TORSEMIDE 479 418 5 52
RAMIPRIL 409 363 6 25
SIMVASTATIN 394 361 7 9
WARFARIN SODIUM 356 317 8 7
BYSTOLIC 336 299 9 29
CRESTOR 312 241 10 15
CLOPIDOGREL 282 253 11 8
PLAVIX 251 223 12 12
PRAVASTATIN SODIUM 226 209 13 13
BISOPROLOL FUMARATE 214 194 14 26
POTASSIUM CHLORIDE 212 205 15 19
AMLODIPINE BESYLATE-BENAZEPRIL 201 176 16 68
LISINOPRIL 197 177 17 1
SPIRONOLACTONE 188 161 18 21
LOSARTAN POTASSIUM 162 162 19 17
METOPROLOL SUCCINATE 152 123 20 4
DIGOXIN 147 141 21 14
LEVOTHYROXINE SODIUM 137 124 22 31
HYDROCHLOROTHIAZIDE 137 124 22 18
FUROSEMIDE 135 122 24 6
LOVAZA 128 102 25 63
BENAZEPRIL HCL 120 106 26 82
RANEXA 119 106 27 22
OMEPRAZOLE 112 111 28 28
LOSARTAN-HYDROCHLOROTHIAZIDE 109 109 29 43
METOPROLOL TARTRATE 103 84 30 2
SOTALOL 102 89 31 24
FENOFIBRATE 93 84 32 53
ACEBUTOLOL HCL 90 72 33 109
DOXAZOSIN MESYLATE 90 90 33 55
EPLERENONE 88 83 35 148
KLOR-CON M20 86 78 36 33
LIPITOR 82 81 37 48
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 78 38 37
COREG CR 71 71 39 121
NEXIUM 69 59 40 47
DIOVAN 68 52 41 30
TRIAMTERENE-HCTZ 66 65 42 72
TRICOR 66 37 42 59
NITROSTAT 63 59 44 23
FLECAINIDE ACETATE 57 40 45 45
FLUDROCORTISONE ACETATE 55 50 46 156
AMIODARONE HCL 55 55 46 20
BISOPROLOL-HYDROCHLOROTHIAZIDE 53 53 48 80
ALLOPURINOL 50 50 49 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 26, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.